Arcadia Biosciences (RKDA) Net Cash Flow (2016 - 2025)
Arcadia Biosciences' Net Cash Flow history spans 12 years, with the latest figure at -$861000.0 for Q4 2025.
- For Q4 2025, Net Cash Flow fell 358.56% year-over-year to -$861000.0; the TTM value through Dec 2025 reached -$4.0 million, down 77.1%, while the annual FY2025 figure was -$4.0 million, 77.1% down from the prior year.
- Net Cash Flow reached -$861000.0 in Q4 2025 per RKDA's latest filing, down from -$256000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $16.8 million in Q1 2021 to a low of -$9.5 million in Q2 2023.
- Average Net Cash Flow over 5 years is -$789400.0, with a median of -$1.7 million recorded in 2024.
- Peak YoY movement for Net Cash Flow: surged 268.85% in 2021, then crashed 358.56% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$6.8 million in 2021, then skyrocketed by 69.35% to -$2.1 million in 2022, then plummeted by 95.38% to -$4.1 million in 2023, then soared by 108.12% to $333000.0 in 2024, then plummeted by 358.56% to -$861000.0 in 2025.
- Per Business Quant, the three most recent readings for RKDA's Net Cash Flow are -$861000.0 (Q4 2025), -$256000.0 (Q3 2025), and -$1.8 million (Q2 2025).